Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 7.12K | $58.6K | $8.24 | Jun 6, 2024 | Direct |
Viracta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | Jun 20, 2024 | Direct | ||
CONTRAFECT Corp | Director | Options (Right to Buy) | 42K | May 17, 2022 | Direct | ||
SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 10.5K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIRX | Viracta Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
SERA | SERA PROGNOSTICS, INC. | Jun 6, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
SERA | SERA PROGNOSTICS, INC. | Jun 8, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
VIRX | Viracta Therapeutics, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
VIRX | Viracta Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
CFRX | CONTRAFECT Corp | May 17, 2022 | 1 | $141K | 4 | May 18, 2022 | Director |
SERA | SERA PROGNOSTICS, INC. | Apr 11, 2022 | 1 | $0 | 4 | Apr 12, 2022 | Director |
SERA | SERA PROGNOSTICS, INC. | Apr 11, 2022 | 0 | $0 | 3 | Apr 12, 2022 | Director |
VIRX | Viracta Therapeutics, Inc. | Aug 16, 2021 | 1 | $0 | 4 | Aug 17, 2021 | Director |
VIRX | Viracta Therapeutics, Inc. | Aug 14, 2021 | 0 | $0 | 3 | Aug 17, 2021 | Director |